Literature DB >> 16314939

Cell type- and region-dependent coxsackie adenovirus receptor expression in the central nervous system.

Annette Persson1, Xiaolong Fan, Bengt Widegren, Elisabet Englund.   

Abstract

Model systems have shown that adenoviral vector mediated transient gene expression can potentially be applied for the treatment of brain tumours, neurodegenerative diseases and brain injuries. Most studies utilized adenovirus serotype 5 (Ad5) based vectors, which as adhesion molecules require the coxsackie adenovirus receptor (CAR) as a critical determinant for cellular infection. In this report, we have systematically characterized CAR expression in the adult human central nervous system (CNS) by using immunohistochemistry. A total of 85 specimens from various CNS regions were investigated for CAR expression in a cell type-dependent context. The most marked staining positivity was found in the choroid plexus and the pituitary gland. The neocortex had scattered positive neurons, while the white matter was mainly negative. We need to consider the possible adverse effects and the possible damage caused by adenoviral gene therapy if the virus-vector also binds to normal brain cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314939     DOI: 10.1007/s11060-005-9055-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.

Authors:  T P Cripe; E J Dunphy; A D Holub; A Saini; N H Vasi; Y Y Mahller; M H Collins; J D Snyder; V Krasnykh; D T Curiel; T J Wickham; J DeGregori; J M Bergelson; M A Currier
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

2.  The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction.

Authors:  C J Cohen; J T Shieh; R J Pickles; T Okegawa; J T Hsieh; J M Bergelson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

3.  Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.

Authors:  Katherine A Rauen; Daniel Sudilovsky; Jason L Le; Karen L Chew; Byron Hann; Vivian Weinberg; Lars D Schmitt; Frank McCormick
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

4.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

5.  Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.

Authors:  H Fechner; A Haack; H Wang; X Wang; K Eizema; M Pauschinger; R Schoemaker; R Veghel; A Houtsmuller; H P Schultheiss; J Lamers; W Poller
Journal:  Gene Ther       Date:  1999-09       Impact factor: 5.250

6.  Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Authors:  J T Douglas; M Kim; L A Sumerel; D E Carey; D T Curiel
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections.

Authors:  M Noutsias; H Fechner; H de Jonge; X Wang; D Dekkers; A B Houtsmuller; M Pauschinger; J Bergelson; R Warraich; M Yacoub; R Hetzer; J Lamers; H P Schultheiss; W Poller
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

8.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

Authors:  R P Tomko; R Xu; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.

Authors:  Markus D Sachs; Katherine A Rauen; Meera Ramamurthy; Jennifer L Dodson; Angelo M De Marzo; Mathew J Putzi; Mark P Schoenberg; Ronald Rodriguez
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

10.  Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.

Authors:  Y Li; R C Pong; J M Bergelson; M C Hall; A I Sagalowsky; C P Tseng; Z Wang; J T Hsieh
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

View more
  18 in total

Review 1.  The potential application of gene therapy in the treatment of traumatic brain injury.

Authors:  Fang Shen; Liang Wen; Xiaofeng Yang; Weiguo Liu
Journal:  Neurosurg Rev       Date:  2007-08-09       Impact factor: 3.042

2.  Coxsackievirus and adenovirus receptor (CAR) mediates trafficking of acid sensing ion channel 3 (ASIC3) via PSD-95.

Authors:  Katherine J D A Excoffon; Abimbola O Kolawole; Nobuyoshi Kusama; Nicholas D Gansemer; Priyanka Sharma; Alesia M Hruska-Hageman; Elena Petroff; Christopher J Benson
Journal:  Biochem Biophys Res Commun       Date:  2012-07-15       Impact factor: 3.575

3.  Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients.

Authors:  Xue Yang; Shuangshuang Li; Huiju Wang; Wanyuan Chen; Xiaozhou Mou; Shibing Wang
Journal:  Oncol Lett       Date:  2018-12-24       Impact factor: 2.967

4.  Helper-Dependent Adenovirus Transduces the Human and Rat Retina but Elicits an Inflammatory Reaction When Delivered Subretinally in Rats.

Authors:  Ian C Han; Erin R Burnight; Mallory J Ulferts; Kristan S Worthington; Stephen R Russell; Elliott H Sohn; Robert F Mullins; Edwin M Stone; Budd A Tucker; Luke A Wiley
Journal:  Hum Gene Ther       Date:  2019-09-26       Impact factor: 5.695

5.  Coxsackie and adenovirus receptor (CAR) is a product of Sertoli and germ cells in rat testes which is localized at the Sertoli-Sertoli and Sertoli-germ cell interface.

Authors:  Claire Q F Wang; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  Exp Cell Res       Date:  2007-02-03       Impact factor: 3.905

6.  Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity.

Authors:  Charleine Zussy; Fabien Loustalot; Felix Junyent; Fabrizio Gardoni; Cyril Bories; Jorge Valero; Michel G Desarménien; Florence Bernex; Daniel Henaff; Neus Bayo-Puxan; Jin-Wen Chen; Nicolas Lonjon; Yves de Koninck; João O Malva; Jeffrey M Bergelson; Monica di Luca; Giampietro Schiavo; Sara Salinas; Eric J Kremer
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

7.  A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

Authors:  Anita Bhattacharyya; Erin McMillan; Serene I Chen; Kyle Wallace; Clive N Svendsen
Journal:  Dev Neurosci       Date:  2009-09-09       Impact factor: 2.984

8.  Helper-Dependent Adenoviral Vectors.

Authors:  Amanda Rosewell; Francesco Vetrini; Philip Ng
Journal:  J Genet Syndr Gene Ther       Date:  2011-10-29

9.  Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons.

Authors:  Scott Dindot; Pasquale Piccolo; Nathan Grove; Donna Palmer; Nicola Brunetti-Pierri
Journal:  Hum Gene Ther       Date:  2011-03-18       Impact factor: 5.695

10.  Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.

Authors:  Francesco Vetrini; Philip Ng
Journal:  Viruses       Date:  2010-09-03       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.